Research shows that transplanted pancreatic cells were able to survive in animal hosts.
Is immunoengineering the key to ensuring that cell therapies can treat disease?
Can turning off genetic switches in therapeutic cells help them avoid attack from the immune system?
Medicine by Design-funded research finds transplanting insulin-producing cells with blood vessels may help reverse diabetes
Researchers have engineered a new method to improve the survival and potency of cell transplants to treat diabetes.
$430,000 investment to study if a type of immune cell could be the key to transplanting insulin-producing cells for diabetes treatment
Medicine by Design and OIRM invest $1.2 million in technologies and research to advance innovation in regenerative medicine
Twelve targeted projects and two post-doctoral fellowships that are expanding the frontiers of stem cell research will share $1.2 million in funding thanks to programs supported jointly by the University of Toronto’s Medicine by Design initiative and the Ontario Institute for Regenerative Medicine.